missing translation for 'onlineSavingsMsg'
Learn More
Learn More
Dihydroergotamine Mesylate 97.0+%, TCI America™
Supplier: TCI America D26331G
Specifications
Dihydroergotamine Mesylate | |
Red-Yellow | |
MFCD00058615 | |
dihydroergotamine mesylate, dihydroergotamine methanesulfonate salt, dihydroergotoxine, prestwick_746, dihydroergotamine methanesulfonate salt, powder, dihydroergotamine mesilate, european pharmacopoeia ep reference standard, dihydroergotamine for peak identification, european pharmacopoeia ep reference standard, dihydroergotamine mesylate, united states pharmacopeia usp reference standard, 4r,7r-n-1s,2s,4r,7s-7-benzyl-2-hydroxy-4-methyl-5,8-dioxo-3-oxa-6,9-diazatricyclo 7.3.0.0^ 2,6 dodecan-4-yl-6-methyl-6,11-diazatetracyclo 7.6.1.0^ 2,7 .0^ 12,16 hexadeca-1 15 ,9,12 16 ,13-tetraene-4-carboxamide; methanesulfonic acid, 6ar,9r-n-2r,5s,10as,10bs-5-benzyl-10b-hydroxy-2-methyl-3,6-dioxooctahydro-8h-oxazolo 3,2-a pyrrolo 2,1-c pyrazin-2-yl-7-methyl-4,6,6a,7,8,9,10,10a-octahydroindolo 4,3-fg quinoline-9-carboxamide methanesulfonate | |
CS(O)(=O)=O.CN1C[C@@H](C[C@H]2[C@H]1CC1=CNC3=CC=CC2=C13)C(=O)N[C@]1(C)O[C@@]2(O)[C@@H]3CCCN3C(=O)[C@H](CC3=CC=CC=C3)N2C1=O | |
679.79 | |
679.79 | |
Crystalline Powder |
6190-39-2 | |
C34H41N5O8S | |
1 g | |
ADYPXRFPBQGGAH-UMYZUSPBSA-N | |
(2R,4R,7R)-N-[(1S,2S,4R,7S)-7-benzyl-2-hydroxy-4-methyl-5,8-dioxo-3-oxa-6,9-diazatricyclo[7.3.0.0²,â¶]dodecan-4-yl]-6-methyl-6,11-diazatetracyclo[7.6.1.0²,â·.0¹²,¹â¶]hexadeca-1(16),9,12,14-tetraene-4-carboxamide; methanesulfonic acid | |
6420006 | |
≥97.0% (HPLC) |
Chemical Identifiers
6190-39-2 | |
679.79 | |
ADYPXRFPBQGGAH-UMYZUSPBSA-N | |
6420006 | |
CS(O)(=O)=O.CN1C[C@@H](C[C@H]2[C@H]1CC1=CNC3=CC=CC2=C13)C(=O)N[C@]1(C)O[C@@]2(O)[C@@H]3CCCN3C(=O)[C@H](CC3=CC=CC=C3)N2C1=O |
C34H41N5O8S | |
MFCD00058615 | |
dihydroergotamine mesylate, dihydroergotamine methanesulfonate salt, dihydroergotoxine, prestwick_746, dihydroergotamine methanesulfonate salt, powder, dihydroergotamine mesilate, european pharmacopoeia ep reference standard, dihydroergotamine for peak identification, european pharmacopoeia ep reference standard, dihydroergotamine mesylate, united states pharmacopeia usp reference standard, 4r,7r-n-1s,2s,4r,7s-7-benzyl-2-hydroxy-4-methyl-5,8-dioxo-3-oxa-6,9-diazatricyclo 7.3.0.0^ 2,6 dodecan-4-yl-6-methyl-6,11-diazatetracyclo 7.6.1.0^ 2,7 .0^ 12,16 hexadeca-1 15 ,9,12 16 ,13-tetraene-4-carboxamide; methanesulfonic acid, 6ar,9r-n-2r,5s,10as,10bs-5-benzyl-10b-hydroxy-2-methyl-3,6-dioxooctahydro-8h-oxazolo 3,2-a pyrrolo 2,1-c pyrazin-2-yl-7-methyl-4,6,6a,7,8,9,10,10a-octahydroindolo 4,3-fg quinoline-9-carboxamide methanesulfonate | |
(2R,4R,7R)-N-[(1S,2S,4R,7S)-7-benzyl-2-hydroxy-4-methyl-5,8-dioxo-3-oxa-6,9-diazatricyclo[7.3.0.0²,â¶]dodecan-4-yl]-6-methyl-6,11-diazatetracyclo[7.6.1.0²,â·.0¹²,¹â¶]hexadeca-1(16),9,12,14-tetraene-4-carboxamide; methanesulfonic acid |
Safety and Handling
RTECSNumber : KE7920000
TSCA : No